AbbVie Stock Will $300: Timing and Risks to Watch
AbbVie’s Q1 2026 results show strong immunology growth even as biosimilar challenges weigh on revenue. Analysts debat...
Identify which cards provide flexible rewards without any fees. Compare your options for optimal rewards.
25,836 articlesAbbVie’s Q1 2026 results show strong immunology growth even as biosimilar challenges weigh on revenue. Analysts debat...
Former BitMEX CEO Arthur Hayes appears to be adding more ETH as critics circle over recent token hype and sales. Look...
A Flutterwave-led Series E values RLUSD at the heart of Africa's payments network, boosting XRP price prediction pros...
May data shows a retail sales surge 0.9%, the strongest in three months, signaling resilience in consumer spending an...
DTE Energy is nearing its 52-week high after a robust first half of 2026, supported by utility earnings and a rising ...
Medicare's first round of drug-price negotiations slashes list prices on 10 widely used drugs by up to 79% starting J...
Analysts issue refreshed Tuesday notes on a slate of large-cap names, signaling where investors may push for upside a...
A dramatic reconfiguration of the Dow Jones Industrial Average will take effect on June 29. Verizon Sunt exits and Al...
A data-driven model now sees roughly 36% upside for Qualcomm stock within a year, even after a choppy period around i...
Two Senate bills would let six-story apartment buildings use a single interior exit stair, a move that could lower co...
Tesla sits at a fair-value crossroads in 2026, with capex and AI initiatives guiding a modest upside. Here’s how inve...
ON Semiconductor slumped about 20% after unveiling an all-stock purchase of Synaptics, triggering questions about dil...